NanoViricides Announces that Clinical Trials of Its Broad-Spectrum Antiviral Drug NV-CoV-2 Have Begun
SHELTON, CT, Jun 29, 2023 – (ACN Newswire via SEAPRWire.com) – NanoViricides, Inc. (NYSE American:NNVC) (the “Company”) reports that clinical trials of its broad-spectrum antiviral […]